Medications & Supplements/Prescription Drugs

Preferred Pharmaceuticals, Inc: Fexofenadine HCl Tablets Recalled for Failed Impurity Specifications

Agency Publication Date: September 24, 2019

Summary

Preferred Pharmaceuticals, Inc. has recalled 79 bottles of Fexofenadine HCl Tablets, 180 mg (a generic version of Allegra) due to the product failing testing for impurities and degradation specifications. This means the medication may contain substances above safe limits or has broken down chemically, which can impact the drug's safety and effectiveness. These specific bottles (90-count size) were distributed to a single physician's office in Gainesville, Florida.

Risk

Medications that fail impurity or degradation standards may contain unintended chemical substances that could cause adverse health effects or result in the medication not working as intended to treat allergy symptoms.

What You Should Do

Check your prescription bottle label to see if you have Fexofenadine HCl Tablets, 180 mg, repackaged by Preferred Pharmaceuticals, Inc.
Verify if your bottle has the National Drug Code (NDC) 68788-6848-09 and matches either lot number G0219K or C1419E, both with an expiration date of 3/2021.
If your medication matches these lot numbers, contact your healthcare provider or pharmacist immediately for guidance on obtaining a replacement and to discuss any health concerns.
Return any unused product to the physician or pharmacy where it was obtained for a refund.
For further instructions, you may contact Preferred Pharmaceuticals, Inc. at their Anaheim, California location.
For additional questions or to report a reaction, contact the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA).

Your Remedy Options

Full Refund

Contact your healthcare provider or pharmacist for guidance.

How to: Return any unused product to the pharmacy for a refund and contact the manufacturer for further instructions.

Affected Products

Product: Fexofenadine HCl Tablets, 180 mg (90 ct.)

Model:

NDC 68788-6848-09

Recall #: D-1877-2019

Lot Numbers:

G0219K (Exp 3/2021)

C1419E (Exp 3/2021)

Additional Information

Agency: Food and Drug Administration (FDA)

Event ID: 83711

Status: Resolved

Manufacturer: Preferred Pharmaceuticals, Inc

Sold By: 1 physician in Gainesville, Florida

Manufactured In: United States

Units Affected: 79 (90 ct.) bottles

Distributed To: Florida

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.

Summary

What You Should Do

Check your prescription bottle label to see if you have Fexofenadine HCl Tablets, 180 mg, repackaged by Preferred Pharmaceuticals, Inc.

Verify if your bottle has the National Drug Code (NDC) 68788-6848-09 and matches either lot number G0219K or C1419E, both with an expiration date of 3/2021.

If your medication matches these lot numbers, contact your healthcare provider or pharmacist immediately for guidance on obtaining a replacement and to discuss any health concerns.

Return any unused product to the physician or pharmacy where it was obtained for a refund.

For further instructions, you may contact Preferred Pharmaceuticals, Inc. at their Anaheim, California location.

For additional questions or to report a reaction, contact the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA).